PRISM for Cancer
(PRISM-AC Trial)
Trial Summary
What is the purpose of this trial?
Multi-Site Randomized Controlled Trial testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults with Advanced Cancer
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Promoting Resilience in Stress Management (PRISM) for cancer patients?
Is the PRISM stress management program safe for cancer patients?
How is the PRISM treatment different from other treatments for cancer?
PRISM (Promoting Resilience in Stress Management) is unique because it focuses on enhancing resilience and managing stress, which can improve psychological well-being and potentially influence physical health outcomes in cancer patients. Unlike traditional treatments that target the cancer itself, PRISM aims to help patients cope with the emotional and psychological challenges of cancer diagnosis and treatment.138910
Research Team
Abby R Rosenberg, MD, MS, MA
Principal Investigator
Dana-Farber Cancer Institute
Eligibility Criteria
This trial is for adolescents and young adults aged 12-24 with advanced cancer, who can speak and read English or Spanish. They should be cognitively able to participate in interviews. It's not open to those whose parents refuse participation (if under 18) or if the patient themselves refuses.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention Adaptation
Adapt and iteratively test the existing PRISM intervention based on established guidelines for intervention development
Treatment
Participants receive the PRISM intervention, which includes four 30-60 minute, in-person, one-on-one sessions plus a facilitated family meeting
Follow-up
Participants are monitored for psychosocial well-being and quality of life outcomes
Treatment Details
Interventions
- Promoting Resilience in Stress Management (PRISM)
Promoting Resilience in Stress Management (PRISM) is already approved in United States for the following indications:
- Chronic Musculoskeletal Pain in Adolescents
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
Pittsburgh Children's Hospital
Collaborator
Children's Hospital Los Angeles
Collaborator
National Cancer Institute (NCI)
Collaborator
University of Pittsburgh Medical Center
Collaborator
Seattle Children's Hospital
Collaborator
Baylor College of Medicine
Collaborator